Patent · US Active

PSMA-targeting compounds and uses thereof

US9776977B2 · kind B2 · utility

12Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2014
Grant dateOct 3, 2017
Priority date
Expiry dateApr 11, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/342
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.